Phase 2 Disc Degeneration Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
EvaluatIon of Autologous Nucleus Pulposus Cells (aNPC) in Degenerative Disc Disease
Intervertebral disc degeneration
ASTEROGENE Biomedical Co. Ltd.12 enrolled1 locationNCT07168603
Recruiting
Phase 2
Efficacy of Intradiscal Injection of Autologous BM-MSC in Subjects With Chronic LBP Due to Multilevel Lumbar IDD
Intervertebral disc degenerationChronic Low-back Pain
Fondazione Policlinico Universitario Campus Bio-Medico52 enrolled1 locationNCT05066334
Recruiting
Phase 2
ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs
Degenerative Disc DiseaseDisc DegenerationLumbar Discogenic Pain
VIVEX Biologics, Inc.110 enrolled5 locationsNCT06615505